Laurion Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,000
Closed -$982K 362
2025
Q4
$982K Buy
+3,000
New +$952K 0.04% 137
2024
Q3
Sell
-8,387
Closed -$2.62M 294
2024
Q2
$2.62M Buy
+8,387
New +$2.46M 0.03% 199
2024
Q1
Sell
-12,611
Closed -$3.69M 519
2023
Q4
$3.63M Buy
+12,611
New +$3.44M 0.03% 260
2022
Q3
Sell
-9,221
Closed -$2.24M 480
2022
Q2
$2.24M Buy
+9,221
New +$2.26M 0.03% 224
2021
Q3
Sell
-1,319
Closed -$322K 675
2021
Q2
$322K Buy
+1,319
New +$324K ﹤0.01% 574
2018
Q4
Sell
-2,902
Closed -$566K 1087
2018
Q3
$602K Sell
2,902
-22,092
-88% -$4.35M 0.01% 793
2018
Q2
$4.61M Buy
24,994
+13,394
+115% +$2.37M 0.04% 368
2018
Q1
$1.98M Buy
+11,600
New +$2.13M 0.02% 629
2017
Q4
Sell
-14,500
Closed -$2.57M 1505
2017
Q3
$2.7M Sell
14,500
-7,300
-33% -$1.29M 0.01% 681
2017
Q2
$3.75M Buy
+21,800
New +$3.55M 0.02% 603
2017
Q1
Sell
-14,989
Closed -$2.49M 1270
2016
Q4
$2.19M Sell
14,989
-10,286
-41% -$1.55M 0.02% 551
2016
Q3
$4.22M Buy
25,275
+13,875
+122% +$2.35M 0.04% 359
2016
Q2
$1.74M Buy
11,400
+4,700
+70% +$731K 0.03% 412
2016
Q1
$1M Buy
+6,700
New +$995K 0.02% 424
2015
Q3
Sell
-97,100
Closed -$14.9M 725
2015
Q2
$14.9M Buy
97,100
+94,800
+4,122% +$15.2M 0.14% 182
2015
Q1
$368K Buy
+2,300
New +$362K 0.01% 274
2014
Q4
Sell
-140,000
Closed -$19.7M 305
2014
Q3
$19.7M Buy
+140,000
New +$18.3M 0.42% 60
2013
Q3
Sell
-200
Closed -$20K 175
2013
Q2
$20K Buy
+200
New +$20.8K ﹤0.01% 145

Other funds holding AMGN

Laurion Capital Management's AMGN Position: Q1 2026 in Review

Laurion Capital Management sold out of Amgen (AMGN) in Q1 2026, closing a stake of 3,000 shares — an estimated $982K sold.

Laurion Capital Management first reported a position in AMGN in Q2 2013 and held it in 18 quarters. The position peaked at $19.7M in Q3 2014. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Laurion Capital Management reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Laurion Capital Management sold 3,000 Amgen shares in Q1 2026, an estimated $982K.
  • Laurion Capital Management first reported a position in Amgen in Q2 2013 and held it in 18 quarters.
  • Laurion Capital Management's Amgen position peaked at $19.7M in Q3 2014.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Laurion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.